For the Inventor, By the Inventor

Enter assignee name

Las Vegas, NV, United States of America

R.p.scherer Technologies, Inc.

USPTO Granted Patents = 117

CIPO Patents = 84

EPO Patents = 49

Trademarks = 21

Forward Citations = 1,123

Loading Chart...

Loading Chart...

251 inventors (with patents filed for the assignee):

David Rabuka (16 out of 40 patents)

Keith Edward Tanner (8 out of 11 patents)

Stepan Chuprakov (7 out of 7 patents)

4. Penelope M Drake (7 out of 10 patents)

5. Lester David Fulper (6 out of 9 patents)

6. Ronald S Vladyka (6 out of 17 patents)

7. Gregory W deHart (5 out of 11 patents)

8. Patrick Holder (5 out of 6 patents)

9. Yun Cheol Kim (5 out of 6 patents)

10. Susan Gerrard Banbury (5 out of 6 patents)

11. Michael Hall (5 out of 6 patents)

12. Elizabeth Youngblood (5 out of 5 patents)

13. Jeanne E Baker (5 out of 14 patents)

14. Romas Alvydas Kudirka (4 out of 18 patents)

15. Jesse M McFarland (4 out of 9 patents)

Core Competencies:

Softgel Capsules

Antibody Conjugates

Twin-Screw Dry Granulation

Oral Delivery Formulations

Abuse Resistant Capsules

Activated Formylglycine-Generating Enzymes

Camptothecine Conjugates

Glycoside Dual-Cleavage Linkers

Mucin-1 Antibodies

Enteric Softgel Capsules

Analytical Methods

Inverse Blow-Fill-Seal Packaging

117 patents: Sort by Forward Citations

1. 12458699 - Formulation for oral delivery of proteins, peptides and small molecules with poor permeability (2025-11-04),

2. 12409143 - Softgel capsules and a method for preparing the softgel capsules (2025-09-09),

3. 12357541 - Two part rotary die encapsulation system (2025-07-15),

4. 12324857 - Apparatus and process for secondary encapsulation of solid inclusions using the rotary die process (2025-06-10),

5. 12296021 - Antibody conjugates and methods of making and using the same (2025-05-13),

6. 12241877 - Analytical method (2025-03-04),

7. 12187810 - Glycoside dual-cleavage linkers for antibody-drug conjugates (2025-01-07),

8. 12187745 - Camptothecine antibody-drug conjugates and methods of use thereof (2025-01-07),

9. 12178912 - Twin-screw dry granulation for producing solid formulations (2024-12-31),

10. 12161605 - Method to relieve stress in capsule shells to reduce propensity to break (2024-12-10),

11. 12133922 - Abuse resistant capsule (2024-11-05),

12. 12102689 - Anti-CD22 antibody-maytansine conjugates and methods of use thereof (2024-10-01),

13. 12090232 - Enteric softgel capsules (2024-09-17),

14. 12018308 - Activated formylglycine-generating enzymes and methods of producing and using the same (2024-06-25),

15. 11980691 - Enteric softgel capsules (2024-05-14),

R.P. Scherer Technologies, Inc. is a leading global provider of advanced drug delivery systems and solid dosage forms. With over 70 years of experience, the company specializes in the development and manufacturing of softgel capsules and other innovative drug delivery technologies. R.P. Scherer's solutions are trusted by pharmaceutical and nutraceutical companies worldwide for their superior bioavailability, patient compliance, and product differentiation. Visit their website for more information and to explore their range of cutting-edge drug delivery solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

117 Patents

#15 in Las Vegas, NV

#21 in Nevada

#3,163 in US

#6,578 in the World

Las Vegas, NV, United States of America

R.p.scherer Technologies, Inc.

Forward Citations = 1,123

251 inventors:

David Rabuka (16 out of 40 patents)

Keith Edward Tanner (8 out of 11 patents)

Stepan Chuprakov (7 out of 7 patents)

4. Penelope M Drake (7 out of 10 patents)

5. Lester David Fulper (6 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…